Raphael Pharmaceutical (RAPH) Cash & Equivalents (2020 - 2025)
Raphael Pharmaceutical (RAPH) posted Cash & Equivalents of $45000.0 for Q4 2025, up 1400.0% sequentially from $3000.0 in Q3 2025, and up 136.84% YoY from $19000.0 in Q4 2024.
Raphael Pharmaceutical (RAPH) Cash & Equivalents (2020 - 2025) Analysis & Trends
Raphael Pharmaceutical has reported Cash & Equivalents for 6 years, with the latest figure at $45000.0 in Q4 2025.
- Quarterly Cash & Equivalents rose 136.84% year-over-year to $45000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $45000.0 (up 136.84% YoY) and the FY2025 annual result came in at $45000.0, up 136.84% from the prior year.
- Cash & Equivalents advanced to $45000.0 in Q4 2025 per RAPH's latest filing, from $3000.0 in the prior quarter.
- Over five years, Cash & Equivalents peaked at $299000.0 in Q3 2023 and troughed at $3000.0 in Q3 2025.
- A 5-year average of $113833.3 and a median of $87000.0 in 2022 frame the typical range for Cash & Equivalents.
- The sharpest annual moves came in 2024 and 2025: Cash & Equivalents soared 655.26% in 2024, then slumped 92.5% in 2025.
- Over 5 years, Cash & Equivalents stood at $153000.0 in 2021, then jumped by 88.24% to $288000.0 in 2022, then slipped by 20.14% to $230000.0 in 2023, then slumped by 91.74% to $19000.0 in 2024, then surged by 136.84% to $45000.0 in 2025.
- According to Business Quant data, Cash & Equivalents over the past three periods registered $45000.0, $3000.0, and $20000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.48 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.89 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 1.80 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 332.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 164.00 Mn |
| 10 | Raphael Pharmaceutical | 28.25 Mn | 28.25 Mn | - | 1,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 45,000.00 |
| Sep 30, 2025 | 3,000.00 |
| Jun 30, 2025 | 20,000.00 |
| Mar 31, 2025 | 50,000.00 |
| Dec 31, 2024 | 19,000.00 |
| Sep 30, 2024 | 40,000.00 |
| Jun 30, 2024 | 120,000.00 |
| Mar 31, 2024 | 287,000.00 |
| Dec 31, 2023 | 230,000.00 |
| Sep 30, 2023 | 299,000.00 |
| Jun 30, 2023 | 111,000.00 |
| Mar 31, 2023 | 38,000.00 |
| Dec 31, 2022 | 288,000.00 |
| Sep 30, 2022 | 93,000.00 |
| Jun 30, 2022 | 135,000.00 |
| Mar 31, 2022 | 81,000.00 |
| Dec 31, 2021 | 153,000.00 |
| Sep 30, 2021 | 37,000.00 |
| Dec 31, 2020 | 95,000.00 |